Humacyte to Provide Investor Update on June 7
DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced an investor update presentation will be available at 9:00 a.m. ET on Monday, June 7 at http://www.humacyte.com/investor_update. The presentation will review the Company’s clinical programs and progress, as well as its scientific platform and current business plans.
The presentation will be available for 30 days.
On February 17, 2021, Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, and Humacyte announced the execution of a definitive business combination agreement along with a fully committed $175 million PIPE financing agreement. The merger transaction is anticipated to close early in the third quarter of 2021.
About Alpha Healthcare Acquisition Corp.
Important Information About the Merger and Where to Find It
Participants in the Solicitation
Humacyte Investor Contact:
Humacyte Media Contact:
Exhibit Hall Grand Opening Reception - Hall D - Sponsored by Dell Expoert Network
Time: 5:00-7:00 pm
Open Source World #TECHSUPERSHOW Exhibit Hall Open